Abstract
Bullous skin disorders associated with PD-1 and PDL-1 inhibitors: Pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) from the Research on Adverse Drug events And Reports (RADAR) Program
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have